TrialHaematologica2019

Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.

Riccardo Bruna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.